array biopharma inc
(ARRY:Consolidated Issue listed on NASDAQ Global Market)
Neil L. Spector M.D.
Member of Scientific Advisory Board, Array BioPharma, Inc.
|Age||Total Calculated Compensation||This person is connected to 15 board members in 2 different organizations across 3 different industries.|
See Board Relationships
Dr. Neil L. Spector, M.D. serves as Director of Translational Research in Oncology, Cancer Drug Development Team of Duke University Medical Center. Dr. Spector also serves as Co-Director of the Experimental Therapeutics Program in the cancer center. He has 20 years of oncology experience. Dr. Spector served as Clinical Advisor of Syndax Pharmaceuticals, Inc. Prior to joining Duke, Dr. Spector served as Director of GlaxoSmithKline's Exploratory Medical Sciences in Oncology, ...
3200 Walnut StreetPhone: 303-381-6600
Boulder, Colorado 80301
Board Members Memberships*There is no Board Members Memberships data available.
New Jersey Medical School, University of Medicine and Dentistry of New Jersey
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Jack Lief Ph.D.||Co-Founder, Chairman, Chief Executive Officer and President|
Arena Pharmaceuticals, Inc.
|James A. Bianco M.D.||Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee|
CTI BioPharma Corp.
|Michael M. Morrissey Ph.D.||Chief Executive Officer, President and Director|
|Mark R. Baker J.D.||Chief Executive Officer, Director and Member of Science & Strategy Committee|
Progenics Pharmaceuticals, Inc.
|Werner Lanthaler MBA,MPA||Chief Executive Officer and Member of Management Board|
|€459.0K||Compensation as of Fiscal Year 2014.|